Abstract:disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that lowering of low-density lipoprotein (LDL) cholesterol is related to a reduction in CHD risk. The reduction of serum cholesterol levels has mainly been accomplished by inhibiting cholesterol biosynthesis or by blocking the absorption of dietary cholesterol. Statins, such as pravastatin, that effectively inhibit cholesterol biosynthesis are HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase) inhibitors and are widely prescribed in the treatment of hypercholesterolemia. Several squalene synthesis inhibitors have been also reported. SCH-48461 (a trans-azetidinone) and 4 ,6 -bis((2-fluorophenyl)carbamoyl) b-O-cellobioside (a steriodal glycoside) have recently been reported to be cholesterol absorption inhibitors. Phytosterols, or plant sterols, are an interesting class of compound due to their application and biological activities. The phytosterols found most frequently in nature are b-sitosterol, campesterol, and stigmasterol. It has been known that they inhibit the absorption of dietary and endogenously produced cholesterol from the small intestine, reducing blood cholesterol concentrations both in animal models and in humans. b-Sitosterol and b-sitostanol fatty acid esters were recently commercialized as food additives to reduce serum cholesterol levels. A novel hydrophilic phytostanol analogue, FM-VP4, was also developed to reduce serum cholesterol levels. However, even with the current therapeutic agents, it is not easy to achieve proper plasma cholesterol levels without side effect. Therefore the discovery of more effective, well-tolerated agents that reduce high cholesterol levels is needed. We here report the synthesis and interesting pharmacologic properties of novel succinamic acid ester derivatives that are bsitosterol analogues, compounds 1 and 2, that have the ability to lower plasma cholesterol levels and that can be more effective cholesterol-lowering alternatives to b-sitosterol and bsitostanol fatty acid esters. Chemistry The synthesis of b-sitosterol analogues 1 and 2 are summarized Chart 1. The b-sitosterol-3-hemisuccinate ester 1 was prepared by the reaction of b-sitosterol and succinic anhydride in toluene with a catalytic amount of DMAP. The chlorination of the resulting acid compound 1 with SOCl2 and then direct amination with appropriate amines afforded N-substituted succinamic acid b-sitosteryl ester derivatives 2. Compounds 2 were also synthesized in 76—92% yields by the reaction of 1 with methyl chloroformate, followed by amination of the activated intermediate. Interestingly, compound 2a (DANA87) was also easily obtained in one step by the direct addition of b-sitosterol to dicyclohexylcarbodiimide (DCC) in 80% yield. It was considered that compound DANA87 was prepared by slow thermal degradation of the May 2004 Notes Chem. Pharm. Bull. 52(5) 597—601 (2004) 597

Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

Discovery of Novel N,N-3-phenyl-3-benzylaminopropionanilides As Potent Inhibitors of Cholesteryl Ester Transfer Protein in Vivo.

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Design and Synthesis of Linear Acetamides as Cholesterol Lowering Agents

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

Synthesis of cholesterol analogues and comparison on their effect on plasma cholesterol with β-Sitosterol

Catalyst-free synthesis of phytosterol diacid monoesters and their competitive effect on the solubilization of cholesterol in model bile mixed micelles

Cholesterol side chain analogs but not its ether analogs possess cholesterol-lowering activity.

Design, Synthesis and Biological Evaluation of Chalcone Derivatives As Potent and Orally Active Hcyp3a4 Inhibitors.

Design, Synthesis and Evaluation of Novel Quinazoline-2,4-dione Derivatives As Chitin Synthase Inhibitors and Antifungal Agents

Novel Guanidinium-Functionalized Stigmasterol for Bile Salt Binding and Serum Cholesterol Reduction: Synthesis, Interaction Mechanisms, and In Vivo Function

Design, Synthesis and Evaluation of Flavonoid Derivatives As Potent AChE Inhibitors.

Design, Synthesis, and Biological Evaluation of 2-Phenoxyalkylhydrazide Benzoxazole Derivatives as Quorum Sensing Inhibitors with Strong Antibiofilm Effect

Design, synthesis and the evaluation of cholinesterase inhibition and blood‐brain permeability of daidzein derivatives or analogs

Chemical Synthesis, Biological Evaluation, and Cheminformatics Analysis of a Group of Chlorinated Diaryl Sulfonamides: Promising Inhibitors of Cholesteryl Ester Transfer Protein

Diacylhydrazine derivatives as novel potential chitin biosynthesis inhibitors: design, synthesis, and structure-activity relationship.

Synthesis of C(7) Modified Chrysin Derivatives Designing to Inhibit Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) As Antibiotics

Effect of a New b-Sitosterol Analogue on Plasma Lipid Concentrations in Rats 1 )